PMID- 19083400 OWN - NLM STAT- MEDLINE DCOM- 20090306 LR - 20220318 IS - 1879-0739 (Electronic) IS - 0271-5317 (Linking) VI - 28 IP - 3 DP - 2008 Mar TI - Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. PG - 137-43 LID - 10.1016/j.nutres.2008.01.008 [doi] AB - Oxidative stress is recognized widely as being associated with various disorders including diabetes, hypertension, and atherosclerosis. It is well established that hydrogen has a reducing action. We therefore investigated the effects of hydrogen-rich water intake on lipid and glucose metabolism in patients with either type 2 diabetes mellitus (T2DM) or impaired glucose tolerance (IGT). We performed a randomized, double-blind, placebo-controlled, crossover study in 30 patients with T2DM controlled by diet and exercise therapy and 6 patients with IGT. The patients consumed either 900 mL/d of hydrogen-rich pure water or 900 mL of placebo pure water for 8 weeks, with a 12-week washout period. Several biomarkers of oxidative stress, insulin resistance, and glucose metabolism, assessed by an oral glucose tolerance test, were evaluated at baseline and at 8 weeks. Intake of hydrogen-rich water was associated with significant decreases in the levels of modified low-density lipoprotein (LDL) cholesterol (ie, modifications that increase the net negative charge of LDL), small dense LDL, and urinary 8-isoprostanes by 15.5% (P < .01), 5.7% (P < .05), and 6.6% (P < .05), respectively. Hydrogen-rich water intake was also associated with a trend of decreased serum concentrations of oxidized LDL and free fatty acids, and increased plasma levels of adiponectin and extracellular-superoxide dismutase. In 4 of 6 patients with IGT, intake of hydrogen-rich water normalized the oral glucose tolerance test. In conclusion, these results suggest that supplementation with hydrogen-rich water may have a beneficial role in prevention of T2DM and insulin resistance. FAU - Kajiyama, Sizuo AU - Kajiyama S AD - Kajiyama Clinic, Kyoto 615-0035, Japan. FAU - Hasegawa, Goji AU - Hasegawa G FAU - Asano, Mai AU - Asano M FAU - Hosoda, Hiroko AU - Hosoda H FAU - Fukui, Michiaki AU - Fukui M FAU - Nakamura, Naoto AU - Nakamura N FAU - Kitawaki, Jo AU - Kitawaki J FAU - Imai, Saeko AU - Imai S FAU - Nakano, Koji AU - Nakano K FAU - Ohta, Mitsuhiro AU - Ohta M FAU - Adachi, Tetsuo AU - Adachi T FAU - Obayashi, Hiroshi AU - Obayashi H FAU - Yoshikawa, Toshikazu AU - Yoshikawa T LA - eng PT - Journal Article PT - Randomized Controlled Trial PL - United States TA - Nutr Res JT - Nutrition research (New York, N.Y.) JID - 8303331 RN - 0 (Biomarkers) RN - 0 (Blood Glucose) RN - 059QF0KO0R (Water) RN - 7YNJ3PO35Z (Hydrogen) SB - IM MH - Biomarkers/blood MH - Blood Glucose/*drug effects/metabolism MH - Cross-Over Studies MH - Diabetes Mellitus, Type 2/blood/drug therapy/*metabolism MH - Dietary Supplements MH - Double-Blind Method MH - Female MH - Glucose Intolerance MH - Glucose Tolerance Test MH - Humans MH - Hydrogen/metabolism/*pharmacology MH - Lipid Metabolism/*drug effects/physiology MH - Male MH - Middle Aged MH - Oxidative Stress/*drug effects MH - Treatment Outcome MH - Water/*pharmacology EDAT- 2008/12/17 09:00 MHDA- 2009/03/07 09:00 CRDT- 2008/12/17 09:00 PHST- 2007/09/05 00:00 [received] PHST- 2007/12/26 00:00 [revised] PHST- 2008/01/17 00:00 [accepted] PHST- 2008/12/17 09:00 [entrez] PHST- 2008/12/17 09:00 [pubmed] PHST- 2009/03/07 09:00 [medline] AID - S0271-5317(08)00023-7 [pii] AID - 10.1016/j.nutres.2008.01.008 [doi] PST - ppublish SO - Nutr Res. 2008 Mar;28(3):137-43. doi: 10.1016/j.nutres.2008.01.008.